Table 6.
Drug | Target(s) | Tumor | Phase | Identifier* |
---|---|---|---|---|
rAd-p53 | TP53 | NSCLC | II | NCT01574729 |
Ad5CMV-p53 | TP53 | NSCLC | I | NCT00004225 |
Mutant p53 peptide vaccine | mt-TP53 | NSCLC | II | NCT00019929 |
AZD-1775 | WEE1 | Ovary | II | NCT01164995 |
Note:
Identifier from ClinicalTrials.gov.
Abbreviations: TP53, tumor protein p53; NSCLC, non-small cell lung cancer.